Banner Top
Sunday, November 27, 2022
Acasti Pharma Inc. (NASDAQ:ACST) Sees Significant Decline in Short Interest

Acasti Pharma Inc. (NASDAQ:ACST – Get Rating) saw a significant decrease in short interest in the month of September. As of September 15th, there was short interest totalling 143,000 shares, a decrease of 7.1% from the August 31st total of 154,000 shares. Based on an average daily trading volume, of 71,200 shares, the days-to-cover ratio is currently 2.0 days. Approximately 0.4% of the shares of the company are short sold.

Institutional Investors Weigh In On Acasti Pharma
An institutional investor recently raised its position in Acasti Pharma stock. Bank of America Corp DE raised its holdings in shares of Acasti Pharma Inc. (NASDAQ:ACST – Get Rating) by 174.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 56,583 shares of the biopharmaceutical company’s stock after purchasing an additional 35,962 shares during the quarter. Bank of America Corp DE owned approximately 0.13% of Acasti Pharma worth $69,000 as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 0.30% of the company’s stock.

Banner Content